On functional and structural heterogeneity of VIM-type metallo-β-lactamases

Journal of Antimicrobial Chemotherapy

Volumn 51, Issue 2, 2003, Pages 257-266

  Docquier, Jean Denis ^a   Lamotte Brasseur, Josette ^b   Galleni, Moreno ^b   Amicosante, Gianfranco ^c   Frère, Jean Marie ^b   Rossolini, Gian Maria ^a  

^a UNIVERSITY OF SIENA   (Italy)

^b UNIVERSITY OF LIÈGE   (Belgium)

^c UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; AMMONIUM SULFATE; AMPICILLIN; AZLOCILLIN; AZTREONAM; BETA LACTAMASE; BIAPENEM; CARBAPENEM DERIVATIVE; CARBENICILLIN; CEFALORIDINE; CEFALOTIN; CEFOTAXIME; CEFOXITIN; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; CHELATING AGENT; IMIPENEM; LATAMOXEF; MEROPENEM; MEZLOCILLIN; NITROCEFIN; PENICILLIN DERIVATIVE; PENICILLIN G; PIPERACILLIN; SULBACTAM; TAZOBACTAM; TEMOCILLIN; TICARCILLIN; UNINDEXED DRUG; ZINC ION;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; BACTERIUM CULTURE; CATALYSIS; CHROMATOGRAPHY; COMPARATIVE STUDY; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME BINDING; ENZYME INACTIVATION; ENZYME KINETICS; ENZYME PURIFICATION; ENZYME RELEASE; ENZYME STRUCTURE; ENZYME SUBSTRATE; ESCHERICHIA COLI; GENETIC CODE; GRAM NEGATIVE BACTERIUM; HOSPITAL INFECTION; MOLECULAR MODEL; MULTIDRUG RESISTANCE; NONHUMAN; PRECIPITATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PSEUDOMONAS AERUGINOSA; REVIEW; SEQUENCE HOMOLOGY; TURNOVER TIME;

AMINO ACID SEQUENCE; BETA-LACTAMASES; CHELATING AGENTS; CHROMATOGRAPHY, GEL; CULTURE MEDIA; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME INHIBITORS; ESCHERICHIA COLI; GENE EXPRESSION REGULATION, BACTERIAL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HYDROLYSIS; ISOENZYMES; KINETICS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; SUBSTRATE SPECIFICITY;

EID: 0037329156     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkg067     Document Type: Review

References (37)

1. Bush, K., Jacoby, G. A. & Medeiros, A. A. (1995). A functional classification scheme for β-lactamases and its correlation with molecular structure. Antimicrobial Agents and Chemotherapy 39, 1211-33.
2. Bush, K. (1999). β-Lactamases of increasing clinical importance. Current Pharmaceutical Design 11, 839-45.
3. Livermore, D. M. & Woodford, N. (2000). Carbapenemases: a problem in waiting? Current Opinion in Microbiology 5, 489-95.
4. Carfi, A., Pares, S., Duée, E., Galleni, M., Duez, C., Frère, J. M. et al. (11995). The 3-D structure of a zinc metallo-β-lactamase from Bacillus cereus reveals a new type of protein fold. EMBO Journal 14, 4914-21.
5. Concha, N. O., Rasmussen, B. A., Bush, K. & Herzberg, O. (1996). Crystal structure of the wide-spectrum binuclear zinc β-lactamase from Bacteroides fragilis. Structure 4, 823-36.
6. Ullah, J. H., Walsh, T. R., Taylor, I. A., Emery, D. C., Verma, C. S., Gamblin, S. J. et al. (1998). The crystal structure of the L1 metallo-β-lactamase from Stenotrophomonas maltophilia at 1.7 Å resolution. Journal of Mololecular Biology 284, 125-36.
7. Concha, N. O., Janson, C. A., Rowling, P., Pearson, S., Cheever, C. A., Clarke, B. P. et al. (2000). Crystal structure of the IMP-1 metallo β-lactamase from Pseudomonas aeruginosa and its complex with a mercaptocarboxylate inhibitor: binding determinants of a potent, broad-spectrum inhibitor. Biochemistry 39, 4288-98.
8. Watanabe, M., Iyobe, S., Inoue, M. & Mitsuhashi, S. (1991). Transferable imipenem resistance in Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy 35, 147-51.
9. Osano, E., Arakawa, Y., Wacharotayankun, R., Ohta, M., Horii, T., Ito, H. et al. (1994). Molecular characterization of an entero-bacterial metallo-β-lactamase found in a clinical isolate of Serratia marcescens that shows imipenem resistance. Antimicrobial Agents and Chemotherapy 38, 71-8.
10. Muramo, K., Takeda, A., Nakamura, Y. & Nakaya, K. (1995). Purification and characterization of metallo-β-lactamase from Serratia marcescens. Microbiology and Immunology 39, 27-33.
11. Laraki, N., Franceschini, N., Rossolini, G. M., Santucci, P., Meunier, C., de Pauw, E. et al. (1999). Biochemical characterization of the Pseudomonas aeruginosa 101/1477 metallo-β-lactamase IMP-1 produced by Escherichia coli. Antimicrobial Agents and Chemotherapy 43, 902-6.
12. Prosperi-Meys, C., Llabres, G., de Seny, D., Paul Soto, R., Hernandez Valladares, M., Laraki, N. et al. (1999). Interaction between class B β-lactamases and suicide substrates of active-site serine β-lactamases. FEBS Letters 443, 109-11.
13. Haruta, S., Yamaguchi, H., Yamamoto, E. T., Eriguchi, Y., Nukaga, M., O'Hara, K. et al. (2000). Functional analysis of the active site of a metallo-β-lactamase proliferating in Japan. Antimicrobial Agents and Chemotherapy 44, 2304-9.
14. IMP allelic variants carried by gene cassettes of different phylogeny. Antimicrobial Agents and Chemotherapy 44, 1229-35.
15. Haruta, S., Yamamoto, E. T., Eriguchi, Y. & Sawai, T. (2001). Characterization of the active-site residues asparagine 167 and lysine 161 of the IMP-1 metallo β-lactamase. FEMS Microbiology Letters 197, 85-9.
16. VIM, a new integron-borne metallo-β-lactamase gene from a Pseudomonas aeruginosa clinical isolate. Antimicrobial Agents and Chemotherapy 43, 1584-90.
17. Poirel, L., Naas, T., Nicholas, D., Collet, L., Bellais, S., Cavallo, J. D. et al. (2000). Characterization of VIM-2, a carbapenem-hydrolyzing metallo-β-lactamase and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France. Antimicrobial Agents and Chemotherapy 44, 891-7.
18. Franceschini, N., Caravelli, B., Docquier, J. D., Galleni, M., Frère, J. M., Amicosante, G. et al. (2000). Purification and biochemical characterization of the VIM-1 metallo-β-lactamase. Antimicrobial Agents and Chemotherapy 44, 3003-7.
19. Yan, J. J., Hsueh, P. R., Ko, W. C., Luh, K. T., Tsai, S. H., Wu, H. M. et al. (2001). Metallo-β-lactamases in clinical Pseudomonas isolates in Taiwan and identification of VIM-3, a novel variant of the VIM-2 enzyme. Antimicrobial Agents and Chemotherapy 45, 2224-8.
20. Mavroidi, A., Tsakris, A., Tzelepi, E., Pournaras, S., Loukova, V. & Tzouvelekis, L. S. (2000) Carbapenem-hydrolysing VIM-2 metallo-β-lactamase in Pseudomonas aeruginosa from Greece. Journal of Antimicrobial Chemotherapy 46, 1041-2.
21. VIM-2-containing integrons from Pseudomonas aeruginosa plasmids encoding the VIM-2 metallo-β-lactamase. FEMS Microbiology Letters 195, 145-50.
22. Sambrook, J., Fritsch, E. F. & Maniatis, T. (2001). Molecular Cloning: A Laboratory Manual, 3rd edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, USA.
23. Pace, C. N., Vajdos, F., Fee, L., Grimsley, G. & Gray, T. (1995). How to measure and predict the molar absorption coefficient of a protein. Protein Science 4, 2411-23.
24. Laemmli, U. K. (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-5.
25. Hagel, J. (1989). Gel filtration. In Principles, High Resolution Methods and Applications (Janson, J. C. & Rydén, L., Eds), pp. 63-106. VCH Publishers Inc., New York, NY, USA.
26. Segel, I. H. (1975). Rapid equilibrium partial and mixed-type inhibition. In Enzyme Kinetics, Behavior and Analysis of Rapid Equilibrium and Steady-State Enzyme Systems, pp. 210-2. John Wiley & Sons, New York, NY, USA.
27. De Meester, F., Joris, B., Reckinger, G., Bellefroid-Bourguignon, C., Frère, J. M. & Waley, S. G. (1987). Automated analysis of enzyme inactivation phenomena. Application to β-lactamases and DD-peptidases. Biochemical Pharmacology 36, 2393-403.
28. Hernandez Valladeres, M., Felici, A., Weber, G., Adolph, H. W., Zeppezauer, M., Rossolini, G. M. et al. (1997). Zn(II) dependence of the Aeromonas hydrophila AE036 metallo-β-lactamase activity and stability. Biochemistry 36, 11534-41.
29. Carfi, A., Duée, E., Paul-Soto, R., Galleni, M., Frère, J. M. & Dideberg, O. (1998). X-ray structure of the ZnII β-lactamase from Bacteroides fragilis in an orthorhombic crystal form. Acta Crystallographica Section D Biological Crystallography 54, 45-57.
30. Pearlman, D., Case, D. A., Caldwell, J. A., Ross, W. S., Cheathman, T. E., Ferguson, D. M. et al. (1995). AMBER 4.1. University of California, San Francisco, CA, USA.
31. Banci, L., Schröder, S. & Kollman, P. A. (1992). Molecular dynamics characterization of the active cavity of carboxypeptidase A and some of its inhibitor adducts. Proteins 13, 288-305.
32. Koradi, R., Billeter, M. & Wüthrich, K. (1996). MOLMOL: a program for display and analysis of macromolecular structures. Journal of Molecular Graphics 14, 51-5.
33. Galleni, M., Lamotte-Brasseur, J., Rossolini, G. M., Spencer, J., Dideberg, O. & Frère, J. M. (2001). Standard numbering scheme for class B β-lactamases. Antimicrobial Agents and Chemotherapy 45, 660-3.
34. Studier, F. W., Rosenberg, A. H., Dunn, J. J. & Dubendorff, J. W. (1990). Use of T7 RNA polymerase to direct expression of cloned genes. Methods in Enzymology 185, 60-89.
35. Rossolini, G. M., Franceschini, N., Riccio, M. L., Mercuri, P. S., Perilli, M., Galleni, M. et al. (1998). Characterization and sequence of the Chryseobacterium (Flavobacterium) meningosepticum carbapenemase: a new molecular class B β-lactamase showing a broad substrate profile. Biochemical Journal 332, 145-52.
36. Wang, Z., Fast, W., Valentine, A. M. & Benkovic, S. J. (1999). Metallo-β-lactamase: structure and mechanism. Current Opinion in Chemical Biology 3, 614-22.
37. Prosperi-Meys, C., Wouters, J., Galleni, M. & Lamotte-Brasseur, J. (2001). Substrate binding and catalytic mechanism of class B β-lactamases: a molecular modelling study. Cellular and Molecular Life Sciences 58, 2136-43.